Viewing Study NCT01257633


Ignite Creation Date: 2025-12-25 @ 2:56 AM
Ignite Modification Date: 2025-12-31 @ 2:21 AM
Study NCT ID: NCT01257633
Status: COMPLETED
Last Update Posted: 2025-11-17
First Post: 2010-12-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Surgical Treatment of Early Stage Glotto-supraglottic Laryngeal Cancer Via Transoral Resection With Robotic Assistance
Sponsor: Centre Hospitalier Universitaire de Nīmes
Organization:

Study Overview

Official Title: Observational Study on Surgical Treatment of Early Stage (T1-T2) Glotto-supraglottic Laryngeal Cancer Via Transoral Resection With Robotic Assistance
Status: COMPLETED
Status Verified Date: 2015-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The main objective of this study is to determine the rate of healthy surgical margins after tumor resection in transoral robot-assisted surgery for glottic and/or supraglottic early stage (T1-T2) laryngeal cancer.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
2010-A01190-39 OTHER ANSM View